Gastrointestinal
News on in vitro diagnostics for gastrointestinal disease.
Thermo Fisher Scientific Gets FDA Clearance for Neuroendocrine Cancer Assay
The BRAHMS CgA II KRYPTOR immunoassay is for use to track tumor progression for neuroendocrine cancer patients by measuring CgA concentration in serum.
ProPhase Labs to Acquire Stella Diagnostics Esophageal Cancer Screening Test for $4.5M
The agreement gives ProPhase exclusive global rights to Stella's BE-Smart Esophageal Pre-Cancer screening test and related intellectual property assets.
Norway MDx Firm Genetic Analysis Adds European Distributor
The Oslo-based company declined to name the partner but said both companies were "in the launch phase" for select European markets.
Thermo Fisher Scientific Obtains CE-IVD Mark for PCR-Based GI Bacteria Panel
The assay, registered under IVDD this May, can detect a range of common GI bacteria in stool samples with more than 98 percent sensitivity and specificity.
The flow cytometry test detects two liver disease biomarkers that can be used to provide information about disease severity.